[HTML][HTML] Profiling estrogen, progesterone, and androgen receptors in colorectal cancer in relation to gender, menopausal status, clinical stage, and tumour sidedness
Background Although estrogen (ERα/ERβ), progesterone (PGR), and androgen (AR)
receptors are pathologically altered in colorectal cancer (CRC), their simultaneous …
receptors are pathologically altered in colorectal cancer (CRC), their simultaneous …
Profiling estrogen, progesterone, and androgen receptors in colorectal cancer in relation to gender, menopausal status, clinical stage, and tumour sidedness
B Refaat, A Aslam, S Idris, AH Almalki… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Although estrogen (ERα/ERβ), progesterone (PGR), and androgen (AR)
receptors are pathologically altered in colorectal cancer (CRC), their simultaneous …
receptors are pathologically altered in colorectal cancer (CRC), their simultaneous …
[HTML][HTML] Profiling estrogen, progesterone, and androgen receptors in colorectal cancer in relation to gender, menopausal status, clinical stage, and tumour sidedness
B Refaat, A Aslam, S Idris, A Mujalli… - Frontiers in …, 2023 - frontiersin.org
Background Although estrogen (ERα/ERβ), progesterone (PGR), and androgen (AR)
receptors are pathologically altered in colorectal cancer (CRC), their simultaneous …
receptors are pathologically altered in colorectal cancer (CRC), their simultaneous …
[HTML][HTML] Profiling estrogen, progesterone, and androgen receptors in colorectal cancer in relation to gender, menopausal status, clinical stage, and tumour sidedness
B Refaat, A Aslam, S Idris, AH Almalki… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Background Although estrogen (ERα/ERβ), progesterone (PGR), and androgen (AR)
receptors are pathologically altered in colorectal cancer (CRC), their simultaneous …
receptors are pathologically altered in colorectal cancer (CRC), their simultaneous …
Profiling estrogen, progesterone, and androgen receptors in colorectal cancer in relation to gender, menopausal status, clinical stage, and tumour sidedness.
B Refaat, A Aslam, S Idris, AH Almalki… - Frontiers in …, 2023 - europepmc.org
Background Although estrogen (ERα/ERβ), progesterone (PGR), and androgen (AR)
receptors are pathologically altered in colorectal cancer (CRC), their simultaneous …
receptors are pathologically altered in colorectal cancer (CRC), their simultaneous …
Profiling estrogen, progesterone, and androgen receptors in colorectal cancer in relation to gender, menopausal status, clinical stage, and tumour sidedness
B Refaat, A Aslam, S Idris, AH Almalki… - Frontiers in …, 2023 - jglobal.jst.go.jp
Profiling estrogen, progesterone, and androgen receptors in colorectal cancer in relation to
gender, menopausal status, clinical stage, and tumour sidedness | Article Information | J-GLOBAL …
gender, menopausal status, clinical stage, and tumour sidedness | Article Information | J-GLOBAL …
Profiling estrogen, progesterone, and androgen receptors in colorectal cancer in relation to gender, menopausal status, clinical stage, and tumour sidedness.
B Refaat, A Aslam, S Idris, AH Almalki… - Frontiers in …, 2023 - europepmc.org
Although estrogen (ERα/ERβ), progesterone (PGR), and androgen (AR) receptors are
pathologically altered in colorectal cancer (CRC), their simultaneous expression within the …
pathologically altered in colorectal cancer (CRC), their simultaneous expression within the …